Equinext's Unattributed - II Round

Equinext raised a round of funding on December 04, 2013.

Equinexts develops, manufactures, and sells an injectable reagent for the treatment of equine ligament, tendon tissue damage (lesions), and stifle joint injury occurring in all breeds of working and …

Articles about Equinext's Unattributed - II Round: